Something is quietly eroding the value of every raise, every bonus, and every compensation strategy employers put on the table. It isn't inflation – at least, not in the traditional sense. It's the relentless rise of health care costs, and it's pulling wages backward.
According to the Federal Reserve Bank of New York's February 2026 regional business surveys, firms that provide health insurance to their workers reported that if not for rising health care costs, they would have raised wages by roughly an additional percentage point. Instead, many absorbed the increases, reduced benefits, or shifted more costs to employees. Employer-sponsored family health insurance premiums now average nearly $27,000 per year, and costs are projected to climb another 7% or more in 2026.
This should raise a fundamental question benefits advisors and employers: are the strategies we're using to manage health care costs actually solving the problem, or are they just rearranging who pays for it?
The trade-off employers never intended to make
Most employers don't set out to suppress wages. When health care costs outpace revenue growth and inflation, employers are forced into a difficult trade-off: wages or health care. Compressed compensation limits an employer's ability to attract and retain talent, while employees who see flat paychecks alongside rising out-of-pocket costs begin to question whether their benefits package is actually benefiting them.
This dynamic chips away at morale, drives turnover, and makes it harder for companies to differentiate on total rewards. Workers are being hit from both sides by stagnant wages and increasing cost-sharing. The result is a workforce that feels the squeeze even when the economy is technically expanding.
Why the usual playbook falls short
The most common approaches to managing health care costs focus on utilization management, premium negotiations, and network design. These are all important levers, but they're limited by the fact that they operate downstream. They attempt to control cost after care has already escalated.
Consider musculoskeletal (MSK) conditions, which rank among the top two cost drivers for large employers year after year. MSK conditions affect more than a third of U.S. adults and account for an outsized share of total medical spending. What makes MSK costs especially stubborn is not just their prevalence but the way they escalate. A manageable issue – say, a new episode of low back pain – often follows a fragmented, drawn-out pathway: a primary care visit, a referral to physical therapy with a weeks-long wait, imaging, a specialist consultation, an injection, and possibly surgery. Along the way, no single provider owns the trajectory of care. Each step adds cost, and none is accountable for whether the issue is actually resolved.
This pattern isn't limited to MSK. It's a structural problem across health care: conditions that could be resolved early instead linger, generating repeat utilization, diagnostic redundancy, and care escalation. The cost compounds, premiums rise, and wages take the hit.
The gap between engagement and resolution
Over the past several years, a wave of digital health solutions and point solutions has entered the employer benefits space. Many of them are well-designed and address legitimate needs like access, engagement, and convenience, but there is a meaningful difference between engaging a patient and resolving their condition.
A digital MSK platform that helps a member complete a series of exercises is delivering engagement. A network that provides access to a specialist is delivering access. A utilization management program that gates certain procedures is delivering control.
But who is accountable for making sure that the member's condition is resolved, and resolved efficiently, completely, and without unnecessary escalation?
That distinction matters. When care activity is measured but outcomes aren't, employers end up funding a cycle of engagement without ever closing the loop on cost.
How unresolved care feeds the wage problem
The connection between unresolved clinical conditions and wage suppression is more direct than most people realize. When a condition like chronic low back pain goes unresolved, it generates downstream utilization in the form of additional office visits, advanced imaging, specialist referrals, procedures, and in some cases, surgical interventions that may not have been necessary with earlier, more targeted care.
That utilization drives claims. Claims drive premiums. Premiums are what force employers to choose between compensation and coverage. Employees end up absorbing the impact from both directions as their wages stagnate and their out-of-pocket costs grow.
This is the cycle employers have an opportunity to interrupt. It won't happen by shifting cost, but instead by reducing the total volume of unnecessary care.
Two pathways, two very different outcomes
To illustrate the stakes, consider two scenarios for an employee with a new musculoskeletal complaint.
In the first scenario, the employee calls their primary care physician, waits for an appointment, receives a referral to physical therapy, waits again, begins treatment, and if the issue doesn't resolve, gets referred for imaging, then to a specialist, then to an injection, and potentially to surgery. The process can stretch across months and involve multiple providers, none of whom own the overall pathway. Cost accumulates at every step.
In the second scenario, the employee starts with a triage clinician who serves as the clinical quarterback. From the first interaction, a real clinical decision is made.
The clinician determines whether the condition meets medical necessity for treatment. If it does, the patient is directed to the most appropriate provider and conservative care approach from the start, with a clear plan to resolve the issue.
If it does not, the patient is not automatically routed into treatment. In some cases, reassurance and education are all that's needed. In others, a targeted digital prevention or wellness program may be introduced based on the patient's needs and willingness to engage.
If the condition requires escalation, the patient is guided directly to a vetted specialist with a clear clinical rationale and bypasses months of trial and error.
In this model, the pathway is not fragmented. It is owned, guided, and adjusted based on the patient's response.
The difference in cost between these two pathways is significant, as is the difference in the employee's experience. This means less time in pain, less time away from work, and less frustration navigating a system that feels like it isn't designed to help them.
What employers can do differently in 2026
Employers and their benefits advisors don't have to accept rising premiums as an inevitability. Breaking the cycle requires asking different questions of every vendor and partner in the benefits ecosystem.
Evaluate where care begins. The entry point matters. When an employee's first clinical interaction is with a provider who can diagnose, treat, and guide next steps from the start, the entire downstream cost trajectory changes. Models that prioritize early, accurate diagnosis and immediate intervention reduce the fragmentation that drives cost escalation.
Prioritize resolution over engagement. Engagement metrics (app downloads, session completions, satisfaction scores) tell you whether members interacted with a program. They don't tell you whether their condition was resolved. When evaluating vendors and programs, employers should look for evidence of clinical resolution and measurable downstream impact on utilization and cost.
Look beyond upfront cost. A lower per-visit cost doesn't translate to lower total cost if it takes five visits, two referrals, and an imaging study to reach the same outcome that a more targeted model achieves in one or two. Employers should measure total episode cost, not just unit price.
Ask every vendor: who owns the outcome? This may be the single most critical question an employer can ask. Some vendors own access. Some own engagement. Some own a visit. Is anyone accountable for the end result? Accountable for whether the patient's condition is actually resolved? If no one can answer that question, the cost cycle is likely to continue.
Breaking the cycle
The health care cost problem isn't going to be solved by shifting expenses from one column to another. It's going to be solved by reducing the volume of unnecessary, unresolved care that drives those expenses in the first place.
Employers have more leverage than they think. Using it effectively means moving past the traditional playbook of premium negotiations and utilization controls and toward a fundamentally different question: are the care models we're paying for actually resolving conditions, or are they just managing the process of being sick?
The employers and advisors who ask that question, and act on the answer, will be the ones who find a way to invest in their people again and break away from a system that delivers activity without accountability.
In 2026, the cost cycle doesn't have to repeat. But it will, unless someone decides to break it.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.